Integer (NYSE:ITGR) Price Target Raised to $127.00

Integer (NYSE:ITGR) had its price objective boosted by Wells Fargo & Company from $84.00 to $127.00 in a research note released on Tuesday morning,Benzinga reports. The firm currently has an equal weight rating on the medical equipment provider’s stock.

A number of other brokerages have also recently commented on ITGR. Citigroup lifted their price target on Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 8th. Freedom Capital upgraded shares of Integer to a “strong-buy” rating in a report on Wednesday, July 22nd. Raymond James Financial downgraded shares of Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a report on Monday, July 20th. Finally, Oppenheimer cut shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Monday. One research analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, Integer presently has a consensus rating of “Hold” and a consensus target price of $109.86.

Integer Stock Up 0.5%

Shares of NYSE:ITGR opened at $125.57 on Tuesday. The stock has a market capitalization of $4.27 billion, a P/E ratio of 34.31, a price-to-earnings-growth ratio of 2.98 and a beta of 0.61. The stock’s 50-day moving average price is $96.70 and its 200-day moving average price is $90.12. The company has a current ratio of 3.73, a quick ratio of 2.38 and a debt-to-equity ratio of 0.75. Integer has a 12-month low of $62.00 and a 12-month high of $126.14.

Integer (NYSE:ITGR) last released its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. The company had revenue of $464.11 million during the quarter, compared to analyst estimates of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.Integer’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.55 EPS. On average, equities analysts anticipate that Integer will post 6.04 earnings per share for the current year.

Institutional Trading of Integer

Large investors have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC raised its holdings in Integer by 48.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 117 shares in the last quarter. Salomon & Ludwin LLC increased its position in shares of Integer by 46.8% during the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 118 shares during the period. Harbor Investment Advisory LLC bought a new position in Integer in the second quarter worth about $42,000. TD Private Client Wealth LLC lifted its holdings in Integer by 1,037.5% in the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 415 shares during the period. Finally, Parkside Financial Bank & Trust lifted its holdings in Integer by 135.5% in the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 267 shares during the period. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.